R. Dossani, M. Waqas, A. Baig, D. Popoola, J. Cappuzzo, H. Rai, A. Monteiro, A. Levy, E. Hashmi, J. Davies, E. Levy, A. Siddiqui
{"title":"E-130 Use of walrus balloon guide catheter for proximal flow arrest during neurointerventional procedures","authors":"R. Dossani, M. Waqas, A. Baig, D. Popoola, J. Cappuzzo, H. Rai, A. Monteiro, A. Levy, E. Hashmi, J. Davies, E. Levy, A. Siddiqui","doi":"10.1136/neurintsurg-2021-snis.225","DOIUrl":null,"url":null,"abstract":"effectiveness among the different devices. Disclosures M. Waqas: None. R. Dossani: None. M. Alkhaldi: None. J. Neveu: None. J. Cappuzzo: None. J. Liam: None. A. Khan: None. V. Lazarov: None. A. Monteiro: None. J. Davies: 1; C; National Center for Advancing Translational Sciences of the National Institutes of Health under award number KL2TR001413 to the University at Buffalo. A. Siddiqui: 2; C; Amnis Therapeutics, Boston Scientific, Canon Medical Systems USA Inc., Cerebrotech Medical Systems Inc., Cerenovus, Corindus Inc., Endostream Medical Ltd., Imperative Care, Inc. Integra LifeSciences C. 4; C; Adona Medical, Inc, Amnis Therapeutics, (Purchased by Boston Scientific October 2017), Blink TBI Inc., Buffalo Technology Partners Inc., Cerebrotech Medical Systems, Inc., Cognition Medical, Endostrea. E. Levy: 2; C; Claret Medical, GLG Consulting, Guidepoint Global, Imperative Care, Medtronic, Rebound, StimMed;. 4; C; NeXtGen Biologics, RAPID Medical, Claret Medical, Cognition Medical, Imperative Care (formerly the Stroke Project), Rebound Therapeutics, StimMed, Three Rivers Medical.","PeriodicalId":239958,"journal":{"name":"Electronic poster abstracts","volume":"44 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2021-07-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Electronic poster abstracts","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1136/neurintsurg-2021-snis.225","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
effectiveness among the different devices. Disclosures M. Waqas: None. R. Dossani: None. M. Alkhaldi: None. J. Neveu: None. J. Cappuzzo: None. J. Liam: None. A. Khan: None. V. Lazarov: None. A. Monteiro: None. J. Davies: 1; C; National Center for Advancing Translational Sciences of the National Institutes of Health under award number KL2TR001413 to the University at Buffalo. A. Siddiqui: 2; C; Amnis Therapeutics, Boston Scientific, Canon Medical Systems USA Inc., Cerebrotech Medical Systems Inc., Cerenovus, Corindus Inc., Endostream Medical Ltd., Imperative Care, Inc. Integra LifeSciences C. 4; C; Adona Medical, Inc, Amnis Therapeutics, (Purchased by Boston Scientific October 2017), Blink TBI Inc., Buffalo Technology Partners Inc., Cerebrotech Medical Systems, Inc., Cognition Medical, Endostrea. E. Levy: 2; C; Claret Medical, GLG Consulting, Guidepoint Global, Imperative Care, Medtronic, Rebound, StimMed;. 4; C; NeXtGen Biologics, RAPID Medical, Claret Medical, Cognition Medical, Imperative Care (formerly the Stroke Project), Rebound Therapeutics, StimMed, Three Rivers Medical.